Skip to search formSkip to main contentSkip to account menu

sulbutiamine

Known as: 2-isobutyrylthiamine disulfide, Propanoic acid, 2-methyl-, dithiobis(3-(1-(((4-amino-2-methyl-5-pyrimidinyl)methyl)formylamino)ethylidene)-3,1-propanediyl) ester, sulbutiamin 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

ArcalionEnerion

Broader (1)

Thiamine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Role of the Synthetic B1 Vitamin Sulbutiamine on Health
Sulbutiamine is a thiamine derivative developed in Japan in the mid-60's as a beriberi treatment drug. Since then, different… 
2019
2019
Thiamine and benfotiamine protect neuroblastoma cells against paraquat and β-amyloid toxicity by a coenzyme-independent mechanism
Highly Cited
2012
Highly Cited
2012
Detection of hazardous weight-loss substances in adulterated slimming formulations using ultra-high-pressure liquid chromatography with diode-array detection
The presence on the market of illegal products for slimming purposes or the treatment of overweight is a public health issue… 
2010
2010
Sulbutiamine Counteracts Trophic Factor Deprivation Induced Apoptotic Cell Death in Transformed Retinal Ganglion Cells
Sulbutiamine is a highly lipid soluble synthetic analogue of vitamin B1 and is used clinically for the treatment of asthenia. The… 
2007
2007
[Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease].
The efficacy of the inhibitors of acetylcholinesterase in Alzheimer's Disease (AD) is moderated and some patients do not respond… 
2000
2000
[Effects of sulbutiamine (Arcalion 200) on psycho-behavioral inhibition in major depressive episodes].
UNLABELLED Psycho-behavioural inhibition is characteristic of major depressive disorder and frequently recedes after the other… 
Review
1999
Review
1999
Pharmacologic and therapeutic features of sulbutiamine.
Asthenia is the most frequent medical reason for people seeking help from their physician. In 75% of cases, the cause is… 
1999
1999
[Treatment of chronic postinfectious fatigue: randomized double-blind study of two doses of sulbutiamine (400-600 mg/day) versus placebo].
PURPOSE Chronic fatigue remains a medical mystery and a therapeutic failure. The subgroup of chronic fatigue postinfectious… 
1994
1994
The compartmentation of phosphorylated thiamine derivatives in cultured neuroblastoma cells.
1994
1994
Chloride permeability of rat brain membrane vesicles correlates with thiamine triphosphate content
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)